<?xml version="1.0" encoding="UTF-8"?>
<ref id="B117-microorganisms-08-01934">
 <label>117.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mayer</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Guerrero</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Rodríguez</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Taglialatela-Scafati</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Nakamura</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Fusetani</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Marine pharmacology in 2014–2015: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, antiviral, and anthelmintic activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action</article-title>
  <source>Mar. Drugs</source>
  <year>2020</year>
  <volume>18</volume>
  <fpage>5</fpage>
 </element-citation>
</ref>
